AMPHASTAR PHARMACEUTICALS IN NOTE 2.000% 3/1

AMPHASTAR PHARMACEUTICALS IN NOTE 2.000% 3/1 is a security (CUSIP 03209RAB9) tracked across SEC portfolio filings. 38 institutional managers reported $328.3M on Form 13F as of 2026-06-30; 3 registered fund positions totaling $15.6M via N-PORT as of 2026-04-30.

Summary

Top institutional holders (Form 13F)

Showing 15 of 38 managers by value.

ManagerLocationValueShares
Context Capital Management, LLCLAJOLLA, CA$85.2M93,631,000
Linden Advisors LPNew York, NY$84.6M93,574,000
CAMDEN ASSET MANAGEMENT L P /CALos Angeles, CA$37.8M41,827,000
OAKTREE CAPITAL MANAGEMENT LPLOS ANGELES, CA$34.5M38,036,000
Wellesley Asset ManagementWELLESLEY, MA$23.6M26,026,000
Empyrean Capital Partners, LPLOS ANGELES, CA$18.2M20,265,000
MORGAN STANLEYNEW YORK, NY$6.0M6,600,000
Russell Investments Group, Ltd.Seattle, WA$5.5M6,007,000
BlackRock, Inc.New York, NY$5.0M5,525,000
Chicago Capital Management, LLCCHICAGO, IL$5.0M5,440
SILVERBACK ASSET MANAGEMENT LLCCHAPEL HILL, NC$4.6M5,080,000
Calamos Advisors LLCNAPERVILLE, IL$4.5M5,000,000
ADVENT CAPITAL MANAGEMENT /DE/NEW YORK, NY$3.7M4,055,000
FMR LLCBOSTON, MA$3.4M3,803,000
Pinnacle Holdings, LLCTULSA, OK$1.9M2,055,000

Top fund holders (N-PORT)

FundRegistrantValue% of fund
Calamos Market Neutral Income FundCALAMOS INVESTMENT TRUST/IL$9.1M5.18%
Miller Convertible Bond FundMiller Investment Trust$3.8M101.91%
Global Opportunities PortfolioGlobal Opportunities Portfolio$2.7M1.98%

More